GemVax&KAEL Co.,Ltd. (KOSDAQ:082270)
South Korea
· Delayed Price · Currency is KRW 43,550
+4,500 (11.52%)
At close: Mar 6, 2026
GemVax&KAEL Revenue
GemVax&KAEL had revenue of 17.98B KRW in the quarter ending September 30, 2025, with 41.16% growth. This brings the company's revenue in the last twelve months to 73.64B, up 17.39% year-over-year. In the year 2024, GemVax&KAEL had annual revenue of 62.69B, down -13.18%.
Revenue (ttm)
73.64B
Revenue Growth
+17.39%
P/S Ratio
25.30
Revenue / Employee
404.62M
Employees
182
Market Cap
1,863.05B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 62.69B | -9.52B | -13.18% |
| Dec 31, 2023 | 72.21B | -3.60B | -4.74% |
| Dec 31, 2022 | 75.80B | 15.43B | 25.56% |
| Dec 31, 2021 | 60.37B | -5.29B | -8.06% |
| Dec 31, 2020 | 65.66B | 23.00B | 53.91% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hyulim ROBOT | 210.97B |
| MNC Solution Co.,Ltd | 266.42B |
| SPG Co., Ltd. | 355.92B |
| Creative & Innovative System | 455.63B |
| ROBOTIS | 34.11B |
| Neuromeka | 19.14B |
| SFA Engineering | 1,712.50B |
| Fine Semitech | 288.07B |